Catalyst Wire Dossier Catalyst Wire Dossier

Empasiprubart

· argenx
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Empasiprubart, covering 2025-09-25 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP [Phase 3]

See pricing